Sharda Cropchem Zukünftiges Wachstum
Future Kriterienprüfungen 4/6
Sharda Cropchem wird ein jährliches Gewinn- und Umsatzwachstum von 29.9% bzw. 14.8% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 29.9% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 14.5% betragen.
Wichtige Informationen
29.9%
Wachstumsrate der Gewinne
29.9%
EPS-Wachstumsrate
Chemicals Gewinnwachstum | 22.9% |
Wachstumsrate der Einnahmen | 14.8% |
Zukünftige Eigenkapitalrendite | 14.5% |
Analystenabdeckung | Low |
Zuletzt aktualisiert | 29 Oct 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Revenue Beat: Sharda Cropchem Limited Exceeded Revenue Forecasts By 17% And Analysts Are Updating Their Estimates
Oct 30Sharda Cropchem Limited Just Beat Revenue Estimates By 10%
Jul 27Recent updates
Sharda Cropchem Limited (NSE:SHARDACROP) Soars 43% But It's A Story Of Risk Vs Reward
Nov 06Revenue Beat: Sharda Cropchem Limited Exceeded Revenue Forecasts By 17% And Analysts Are Updating Their Estimates
Oct 30We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Sharda Cropchem Limited's (NSE:SHARDACROP) CEO For Now
Aug 03Sharda Cropchem Limited Just Beat Revenue Estimates By 10%
Jul 27Sharda Cropchem (NSE:SHARDACROP) Has Affirmed Its Dividend Of ₹3.00
Jul 18Sharda Cropchem's (NSE:SHARDACROP) Soft Earnings Are Actually Better Than They Appear
Jul 17Why Investors Shouldn't Be Surprised By Sharda Cropchem Limited's (NSE:SHARDACROP) 29% Share Price Surge
Jul 02Does This Valuation Of Sharda Cropchem Limited (NSE:SHARDACROP) Imply Investors Are Overpaying?
Jun 05What Does Sharda Cropchem Limited's (NSE:SHARDACROP) Share Price Indicate?
Apr 04Need To Know: Analysts Just Made A Substantial Cut To Their Sharda Cropchem Limited (NSE:SHARDACROP) Estimates
Oct 27Analysts Just Made A Major Revision To Their Sharda Cropchem Limited (NSE:SHARDACROP) Revenue Forecasts
Jul 26Sharda Cropchem (NSE:SHARDACROP) Is Paying Out A Dividend Of ₹3.00
Jul 09Is It Too Late To Consider Buying Sharda Cropchem Limited (NSE:SHARDACROP)?
Jun 07Sharda Cropchem (NSE:SHARDACROP) Is Paying Out A Dividend Of ₹3.00
Jan 27At ₹498, Is Sharda Cropchem Limited (NSE:SHARDACROP) Worth Looking At Closely?
Dec 06Do Sharda Cropchem's (NSE:SHARDACROP) Earnings Warrant Your Attention?
Sep 22Sharda Cropchem's (NSE:SHARDACROP) Dividend Will Be ₹3.00
Jul 20Sharda Cropchem (NSE:SHARDACROP) Will Pay A Dividend Of ₹3.00
Jul 06When Should You Buy Sharda Cropchem Limited (NSE:SHARDACROP)?
Jun 15Is There An Opportunity With Sharda Cropchem Limited's (NSE:SHARDACROP) 41% Undervaluation?
May 31I Ran A Stock Scan For Earnings Growth And Sharda Cropchem (NSE:SHARDACROP) Passed With Ease
May 17Sharda Cropchem (NSE:SHARDACROP) Looks To Prolong Its Impressive Returns
Apr 01We Think Sharda Cropchem (NSE:SHARDACROP) Can Stay On Top Of Its Debt
Mar 03Calculating The Intrinsic Value Of Sharda Cropchem Limited (NSE:SHARDACROP)
Feb 12New Forecasts: Here's What Analysts Think The Future Holds For Sharda Cropchem Limited (NSE:SHARDACROP)
Jan 27Is It Too Late To Consider Buying Sharda Cropchem Limited (NSE:SHARDACROP)?
Jan 26Sharda Cropchem (NSE:SHARDACROP) Will Be Hoping To Turn Its Returns On Capital Around
Dec 27Increases to CEO Compensation Might Be Put On Hold For Now at Sharda Cropchem Limited (NSE:SHARDACROP)
Jul 22Gewinn- und Umsatzwachstumsprognosen
Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
---|---|---|---|---|---|
3/31/2027 | 50,452 | 4,599 | 1,784 | 5,769 | 5 |
3/31/2026 | 43,322 | 3,659 | 1,906 | 5,069 | 5 |
3/31/2025 | 37,529 | 2,638 | 2,023 | 4,118 | 5 |
9/30/2024 | 35,065 | 2,178 | 3,459 | 6,293 | N/A |
6/30/2024 | 33,104 | 1,478 | N/A | N/A | N/A |
3/31/2024 | 31,630 | 319 | 692 | 3,413 | N/A |
12/31/2023 | 32,996 | 873 | N/A | N/A | N/A |
9/30/2023 | 37,176 | 1,910 | 785 | 3,267 | N/A |
6/30/2023 | 38,584 | 2,307 | N/A | N/A | N/A |
3/31/2023 | 40,452 | 3,420 | 842 | 3,283 | N/A |
12/31/2022 | 39,978 | 3,201 | N/A | N/A | N/A |
9/30/2022 | 38,603 | 3,139 | -565 | 2,064 | N/A |
6/30/2022 | 38,019 | 3,338 | N/A | N/A | N/A |
3/31/2022 | 35,798 | 3,493 | 333 | 2,671 | N/A |
12/31/2021 | 32,334 | 3,062 | N/A | N/A | N/A |
9/30/2021 | 28,474 | 2,523 | 1,084 | 3,349 | N/A |
6/30/2021 | 26,294 | 2,394 | N/A | N/A | N/A |
3/31/2021 | 23,956 | 2,292 | 152 | 2,464 | N/A |
12/31/2020 | 21,835 | 2,369 | N/A | N/A | N/A |
9/30/2020 | 20,722 | 1,945 | 1,144 | 2,972 | N/A |
6/30/2020 | 19,714 | 1,698 | N/A | N/A | N/A |
3/31/2020 | 20,030 | 1,647 | -297 | 1,463 | N/A |
12/31/2019 | 18,943 | 1,286 | N/A | N/A | N/A |
9/30/2019 | 19,824 | 1,431 | 1,925 | 3,855 | N/A |
6/30/2019 | 19,680 | 1,649 | N/A | N/A | N/A |
3/31/2019 | 19,976 | 1,763 | 4,131 | 5,561 | N/A |
12/31/2018 | 20,072 | 1,840 | N/A | N/A | N/A |
9/30/2018 | 18,612 | 1,736 | N/A | N/A | N/A |
6/30/2018 | 18,294 | 1,818 | N/A | N/A | N/A |
3/31/2018 | 17,066 | 1,908 | N/A | 170 | N/A |
12/31/2017 | 15,396 | 1,763 | N/A | N/A | N/A |
9/30/2017 | 14,571 | 1,840 | N/A | N/A | N/A |
6/30/2017 | 14,257 | 1,927 | N/A | N/A | N/A |
3/31/2017 | 13,992 | 1,904 | N/A | 1,815 | N/A |
12/31/2016 | 13,229 | 1,918 | N/A | N/A | N/A |
9/30/2016 | 12,663 | 1,861 | N/A | N/A | N/A |
6/30/2016 | 12,563 | 1,795 | N/A | N/A | N/A |
3/31/2016 | 12,221 | 1,751 | N/A | 1,966 | N/A |
12/31/2015 | 10,356 | 1,167 | N/A | N/A | N/A |
9/30/2015 | 10,402 | 1,136 | N/A | N/A | N/A |
6/30/2015 | 10,697 | 1,159 | N/A | N/A | N/A |
3/31/2015 | 10,616 | 1,230 | N/A | 461 | N/A |
12/31/2014 | 10,015 | 1,242 | N/A | N/A | N/A |
9/30/2014 | 9,605 | 1,207 | N/A | N/A | N/A |
6/30/2014 | 8,764 | 1,237 | N/A | N/A | N/A |
3/31/2014 | 7,904 | 1,111 | N/A | 1,563 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: SHARDACROPDas prognostizierte Gewinnwachstum (29.9% pro Jahr) liegt über der Sparquote (6.7%).
Ertrag vs. Markt: SHARDACROPDie Erträge des Unternehmens (29.9% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Indian (18% pro Jahr).
Hohe Wachstumserträge: SHARDACROPEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.
Einnahmen vs. Markt: SHARDACROPDie Einnahmen des Unternehmens (14.8% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Indian (10.5% pro Jahr).
Hohe Wachstumseinnahmen: SHARDACROPDie Einnahmen des Unternehmens (14.8% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: SHARDACROPDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (14.5%).